Despite taking daily medications, over 1/3 of patients with epilepsy continue to have seizures, and many more experience significant adverse side effects from antiepileptic drugs (AED). Though patients may spend as little as 0.01% of their time actually having seizures, they must maintain chronic therapeutic AED levels for years to decades. The reason AEDs are taken daily for seizures that only occur sporadically, and in many cases infrequently, is because patients do not know when a seizure will strike. Arguably the unpredictability of seizures and the adverse cognitive and physical side effects associated with AEDs, are the most disabling aspects of epilepsy. We now have compelling evidence from humans that seizures are not random events, but rather are associated with intracranial EEG (lEEG) changes that occur tens of minutes to hours before clinical events. This research has lead NeuroVista Inc. to develop a seizure advisory system (SAS) that uses iEEG and machine learning algorithms to track the probability of seizure occurrence. Using patient specific algorithms NeuroVista's SAS can forecast periods of increased and decreased seizure likelihood with high sensitivity and specificity, benchmarked against a chance predictor. NeuroVista's SAS has been validated in humans undergoing IEEG monitoring for epilepsy surgery, and has recently been approved for a human pilot clinical trial in Australia. We propose to use the NeuroVista's SAS device to guide the delivery of AEDs. We hypothesize that intelligent delivery of AEDs at times of increased seizure likelihood will effectively prevent clinical seizures. During periods of low seizure likelihood AEDs would not be required, reducing side effects. In this proposal we develop and test neurophysiologically-based responsive pharmacotherapy in naturally occurring canine epilepsy as the first step in creating a new treatment paradigm for medically resistant human partial epilepsy. Naturally occurring canine partial epilepsy is an ideal model for developing this therapy because of the clinical, physiological, and pharmacological similarities between canine and human partial epilepsy. In addition, dogs are large enough to tolerate implantation of the human SAS device. This project will lead to submission of an investigational device exemption to conduct a first-in-human clinical trial of SAS guided responsive AED therapy.
Discl aim er: Please note that the following critiques were prepared by the reviewers prior to the Study Section meeting and are provided in an essentially unedited form. While there is opportunity for the reviewers to update or revise their written evaluation, based upon the group's discussion, there is no guarantee that individual critiques have been updated subsequent to the discussion at the meeting. Therefore, the critiques may not fully reflect the final opinions of th individual reviewers at the close of group discussion or the final majority opinion of the group. Thus the Resume and Summary of Discussion is the final word on what the reviewers actually considered critical at the meeting.

Public Health Relevance

This project lays the foundation for a new treatment paradigm for human partial epilepsy: delivering antiepileptic drug (AED) therapy only during periods of increased probability of seizure onset. Rather than treating patients with chronic daily AEDs, we will validate neurophysiologically-based responsive pharmacotherapy, were patients receive AEDs only when they are needed to prevent seizures.
Discl aim er: Please note that the following critiques were prepared by the reviewers prior to the Study Section meeting and are provided in an essentially unedited form. While there is opportunity for the reviewers to update or revise their written evaluation, based upon the group's discussion, there is no guarantee that individual critiques have been updated subsequent to the discussion at the meeting. Therefore, the critiques may not fully reflect the final opinions of th individual reviewers at the close of group discussion or the final majority opinion of the group. Thus the Resume and Summary of Discussion is the final word on what the reviewers actually considered critical at the meeting.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01NS073557-01A1
Application #
8238695
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Stewart, Randall R
Project Start
2011-09-30
Project End
2017-07-31
Budget Start
2011-09-30
Budget End
2013-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$1,488,343
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Ung, Hoameng; Baldassano, Steven N; Bink, Hank et al. (2017) Intracranial EEG fluctuates over months after implanting electrodes in human brain. J Neural Eng 14:056011
Ung, Hoameng; Davis, Kathryn A; Wulsin, Drausin et al. (2016) Temporal behavior of seizures and interictal bursts in prolonged intracranial recordings from epileptic canines. Epilepsia 57:1949-1957
Baldassano, Steven; Wulsin, Drausin; Ung, Hoameng et al. (2016) A novel seizure detection algorithm informed by hidden Markov model event states. J Neural Eng 13:036011
Davis, Kathryn A; Ung, Hoameng; Wulsin, Drausin et al. (2016) Mining continuous intracranial EEG in focal canine epilepsy: Relating interictal bursts to seizure onsets. Epilepsia 57:89-98
Brinkmann, Benjamin H; Patterson, Edward E; Vite, Charles et al. (2016) Correction: Forecasting Seizures Using Bivariate Intracranial EEG Measures and SVM in Naturally Occurring Canine Epilepsy. PLoS One 11:e0156476
Vuu, Irene; Coles, Lisa D; Maglalang, Patricia et al. (2016) Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy. Front Vet Sci 3:107
Brinkmann, Benjamin H; Patterson, Edward E; Vite, Charles et al. (2015) Forecasting Seizures Using Intracranial EEG Measures and SVM in Naturally Occurring Canine Epilepsy. PLoS One 10:e0133900
Howbert, J Jeffry; Patterson, Edward E; Stead, S Matt et al. (2014) Forecasting seizures in dogs with naturally occurring epilepsy. PLoS One 9:e81920
Coles, Lisa D; Patterson, Edward E; Sheffield, W Douglas et al. (2013) Feasibility study of a caregiver seizure alert system in canine epilepsy. Epilepsy Res 106:456-60